These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 10471383)
1. Cytoskeletal reorganization leads to induction of the urokinase-type plasminogen activator gene by activating FAK and Src and subsequently the Ras/Erk signaling pathway. Irigoyen JP; Nagamine Y Biochem Biophys Res Commun; 1999 Sep; 262(3):666-70. PubMed ID: 10471383 [TBL] [Abstract][Full Text] [Related]
2. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Besser D; Bardelli A; Didichenko S; Thelen M; Comoglio PM; Ponzetto C; Nagamine Y Oncogene; 1997 Feb; 14(6):705-11. PubMed ID: 9038378 [TBL] [Abstract][Full Text] [Related]
3. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Besser D; Presta M; Nagamine Y Cell Growth Differ; 1995 Aug; 6(8):1009-17. PubMed ID: 8547215 [TBL] [Abstract][Full Text] [Related]
4. The role of the cytoskeleton in differentially regulating pressure-mediated effects on malignant colonocyte focal adhesion signaling and cell adhesion. Thamilselvan V; Basson MD Carcinogenesis; 2005 Oct; 26(10):1687-97. PubMed ID: 15917311 [TBL] [Abstract][Full Text] [Related]
6. Role of the actin cytoskeleton in insulin action. Tsakiridis T; Tong P; Matthews B; Tsiani E; Bilan PJ; Klip A; Downey GP Microsc Res Tech; 1999 Oct; 47(2):79-92. PubMed ID: 10523787 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Aguirre Ghiso JA Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Elowe S; Holland SJ; Kulkarni S; Pawson T Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923 [TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. Rovida E; Lugli B; Barbetti V; Giuntoli S; Olivotto M; Dello Sbarba P Biol Chem; 2005 Sep; 386(9):919-29. PubMed ID: 16164417 [TBL] [Abstract][Full Text] [Related]
11. Collagen-mediated survival signaling is modulated by CD45 in Jurkat T cells. Bijian K; Zhang L; Shen SH Mol Immunol; 2007 Jul; 44(15):3682-90. PubMed ID: 17524482 [TBL] [Abstract][Full Text] [Related]
12. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Qi JH; Claesson-Welsh L Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Mitra SK; Lim ST; Chi A; Schlaepfer DD Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501 [TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. Nguyen DH; Webb DJ; Catling AD; Song Q; Dhakephalkar A; Weber MJ; Ravichandran KS; Gonias SL J Biol Chem; 2000 Jun; 275(25):19382-8. PubMed ID: 10777511 [TBL] [Abstract][Full Text] [Related]
15. Non-redundant role of Shc in Erk activation by cytoskeletal reorganization. Faisal A; Kleiner S; Nagamine Y J Biol Chem; 2004 Jan; 279(5):3202-11. PubMed ID: 14576154 [TBL] [Abstract][Full Text] [Related]
16. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells. Lee JS; von der Ahe D; Kiefer B; Nagamine Y Nucleic Acids Res; 1993 Jul; 21(15):3365-72. PubMed ID: 8346015 [TBL] [Abstract][Full Text] [Related]
17. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway. Irigoyen JP; Besser D; Nagamine Y J Biol Chem; 1997 Jan; 272(3):1904-9. PubMed ID: 8999879 [TBL] [Abstract][Full Text] [Related]
18. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419 [TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. Kobayashi-Sakamoto M; Isogai E; Holen I Eur J Haematol; 2010 Jul; 85(1):26-35. PubMed ID: 20331738 [TBL] [Abstract][Full Text] [Related]